arrow
W

William C. Weldon

centers for disease control & prevention - usa
H指数:43
被引数:1.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Co-administration of Oral Cholera Vaccine With Oral Polio Vaccine Among Bangladeshi Young Children: A Randomized Controlled Open Label Trial to Assess Interference

孟加拉国幼儿中口服霍乱疫苗与口服脊髓灰质炎疫苗的联合接种:一项评估相互干扰的随机对照开放标签试验

2022-09-222
OAAI
Fecal Shedding of 2 Novel Live Attenuated Oral Poliovirus Type 2 Vaccine Candidates by Healthy Infants Administered Bivalent Oral Poliovirus Vaccine/Inactivated Poliovirus Vaccine: 2 Randomized Clinical Trials

健康婴儿服用二价口服脊髓灰质炎病毒疫苗/灭活脊髓灰质炎病毒疫苗后2种新型减毒活口服脊髓灰质炎病毒2型候选疫苗的粪便脱落: 2项随机临床试验

2021-10-059
OAAI
Assessment of genetic changes and neurovirulence of shed Sabin and novel type 2 oral polio vaccine viruses

shed Sabin和新型2型口服脊髓灰质炎疫苗病毒的遗传变化和神经毒力评估

2021-07-2913
OAAI
Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in healthy adults: two clinical trials
LANCET
IF88.5
2021-01-0143
OAAI
Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in children and infants: two clinical trials
LANCET
IF88.5
2021-01-0154
OAAI
Randomized Controlled Clinical Trial of Bivalent Oral Poliovirus Vaccine and Inactivated Poliovirus Vaccine in Nigerian Children

尼日利亚儿童双价口服脊髓灰质炎病毒疫苗和灭活脊髓灰质炎病毒疫苗的随机对照临床试验

2020-11-241
OAAI
A Randomized Phase 4 Study of Immunogenicity and Safety After Monovalent Oral Type 2 Sabin Poliovirus Vaccine Challenge in Children Vaccinated with Inactivated Poliovirus Vaccine in Lithuania

在立陶宛接种灭活脊髓灰质炎病毒疫苗的儿童中,单价口服2型Sabin脊髓灰质炎病毒疫苗挑战后免疫原性和安全性的随机4期研究

2020-07-0412
OAAI
First Case of 2019 Novel Coronavirus in the United States
2020-03-052.2K
OAAI
Acute Flaccid Myelitis in the United States: 2015-2017
2019-11-0141
OAAI
The safety and immunogenicity of two novel live attenuated monovalent (serotype 2) oral poliovirus vaccines in healthy adults: a double-blind, single-centre phase 1 study
LANCET
IF88.5
2019-07-01115
OAAI